(Q35945429)

English

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort (English)

1 reference

Europe PubMed Central

11 August 2017

0 references

Rochelle P. Walensky

9

1 reference

Europe PubMed Central

11 August 2017

object named as

E Losina

4

0 references

Kenneth A. Freedberg

11

object named as

K A Freedberg

1 reference

Europe PubMed Central

11 August 2017

Bruce R Schackman

6

object named as

B R Schackman

1 reference

Europe PubMed Central

11 August 2017

author name string

B P Linas

1

1 reference

Europe PubMed Central

11 August 2017

B Wang

2

1 reference

Europe PubMed Central

11 August 2017

M Smurzynski

3

1 reference

Europe PubMed Central

11 August 2017

R J Bosch

5

1 reference

Europe PubMed Central

11 August 2017

J Rong

7

1 reference

Europe PubMed Central

11 August 2017

P E Sax

8

1 reference

Europe PubMed Central

11 August 2017

J Schouten

10

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

9 June 2010

1 reference

Europe PubMed Central

11 August 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

11 August 2017

18

1 reference

Europe PubMed Central

11 August 2017

7

1 reference

Europe PubMed Central

11 August 2017

506-512

1 reference

Europe PubMed Central

11 August 2017

Inpatient health services utilization among HIV-infected adult patients in care 2002-2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

The survival benefits of AIDS treatment in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

2 October 2017

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

11 July 2018

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Trends in health care resource use for hepatitis C virus infection in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency virus-infection health care in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2010.01325.X

21 January 2018

Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

24 September 2018

A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3347883

24 September 2018

Derivation and properties of a brief health status assessment instrument for use in HIV disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20546501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2893.2010.01325.X

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35945429&oldid=1862671574"